GlaxoSmithKline LLC | GSK plc | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $3,000,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | $2,300,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | $2,200,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $1,500,000,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | $1,415,000,000 |
Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $950,000,000 |
Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $762,000,000 |
SB Pharmco Puerto Rico Inc. | GSK plc | pharmaceuticals | drug or medical equipment safety violation | 2010 | $750,000,000 |
Serono, S.A. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | $704,000,000 |
Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | $600,000,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | $520,000,000 |
Ranbaxy USA Inc. | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2013 | $500,000,000 |
Google Inc. | Alphabet Inc. | information technology | off-label or unapproved promotion of medical products | 2011 | $500,000,000 |
Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | $490,900,000 |
Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | $430,000,000 |
Cephalon Inc | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $425,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | $422,500,000 |
Guidant LLC | Boston Scientific Corp. | medical equipment and supplies | drug or medical equipment safety violation | 2011 | $296,000,000 |
Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | $203,000,000 |
Endo Health Solutions Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $192,700,000 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $164,000,000 |
Warner Chilcott PLC | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | $125,000,000 |
Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $95,000,000 |
Scios Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $85,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | $81,000,000 |
OtisMed Corp. | Stryker | medical equipment and supplies | drug or medical equipment safety violation | 2014 | $79,560,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | $72,500,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $56,500,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | $55,000,000 |
Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | $45,000,000 |
Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | $41,500,000 |
CareFusion Corp. | Becton Dickinson | medical equipment and supplies | False Claims Act and related | 2014 | $40,100,000 |
InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | $36,900,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | $36,000,000 |
UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $34,000,000 |
Genzyme Corporation | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2015 | $32,587,439 |
Boston Scientific Corp. | Boston Scientific Corp. | medical equipment and supplies | drug or medical equipment safety violation | 2013 | $30,000,000 |
Wyeth-Ayerst Laboratories Division | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2000 | $30,000,000 |
Healthpoint Ltd. and DFB Pharmaceuticals | | | off-label or unapproved promotion of medical products | 2012 | $28,000,000 |
Ethex Corporation | | | drug or medical equipment safety violation | 2010 | $27,600,000 |
McNeil-PPC Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2015 | $25,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $25,000,000 |
Medtronic Inc. | Medtronic | medical equipment and supplies | kickbacks and bribery | 2011 | $23,500,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $14,500,000 |
ConAgra Grocery Products LLC | ConAgra Brands | food products | food safety violation | 2015 | $11,200,000 |
Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | $11,000,000 |
Cell Therapeutics Inc. | | | off-label or unapproved promotion of medical products | 2007 | $10,500,000 |
B. Braun Medical Inc. | B. Braun Melsungen | medical equipment and supplies | drug or medical equipment safety violation | 2016 | $7,800,000 |
Quality Egg LLC | Quality Egg | food products | food safety violation | 2015 | $6,790,000 |
Spectranetics Corporation | Royal Philips | diversified | off-label or unapproved promotion of medical products | 2009 | $5,000,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $4,000,000 |
Atricure Inc. | AtriCure | medical equipment and supplies | off-label or unapproved promotion of medical products | 2010 | $3,760,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $2,800,000 |
GNC Holdings Inc. | Harbin Pharmaceutical Group | pharmaceuticals | drug or medical equipment safety violation | 2016 | $2,250,000 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | $1,200,000 |
Quality Poultry and Seafood Inc. | | | consumer protection violation | 2024 | $1,150,000 |
SCM True Air Technologies, Inc. | | | drug or medical equipment safety violation | 2017 | $711,691 |
Globus Medical Inc. | Globus Medical | medical equipment and supplies | off-label or unapproved promotion of medical products | 2012 | $550,000 |
Roos Foods Inc. | | | food safety violation | 2016 | $100,000 |
True World Foods Chicago, LLC | | | environmental violation | 2008 | $60,000 |